東生華製藥

Home / News

TSH Board of Directors Approved the Consolidated Financial Statements For the Three Months Ended March 31, 2025

TSH Board of Directors Approved the Consolidated Financial Statements For the Three Months Ended March 31, 2025

2025.5.8

...

TSH Biopharm Expands Rare Disease Portfolio, Unlocks New Opportunities in CNS Market

TSH Biopharm Expands Rare Disease Portfolio, Unlocks New Opportunities in CNS Market

2025.5.6

...

Double Milestone for TSH Biopharm: Top 5% in Corporate Governance and Product Expansion into Macau

Double Milestone for TSH Biopharm: Top 5% in Corporate Governance and Product Expansion into Macau

2025.5.1

...

To announce the change of internal audit officer.

To announce the change of internal audit officer.

2025.4.30

...

To announce the change of internal audit officer.

To announce the change of internal audit officer.

2025.4.18

...

Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD.,of executive personnel change

Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD.,of executive personnel change

2025.3.24

...